Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;24(20):1800-1821.
doi: 10.2174/0113895575298181240410041029.

1,3,4-Oxadiazole Scaffold in Antidiabetic Drug Discovery: An Overview

Ojasvi Gupta  1 , Gita Chawla  1 , Tathagata Pradhan  1
Affiliations
Review

1,3,4-Oxadiazole Scaffold in Antidiabetic Drug Discovery: An Overview

Ojasvi Gupta et al. Mini Rev Med Chem. 2024.

Abstract

Diabetes mellitus is one of the biggest challenges for the scientific community in the 21st century. With the increasing number of cases of diabetes and drug-resistant diabetes, there is an urgent need to develop new potent molecules capable of combating this cruel disease. Medicinal chemistry concerns the discovery, development, identification, and interpretation of the mode of action of biologically active compounds at the molecular level. Oxadiazole-based derivatives have come up as a potential option for antidiabetic drug research. Oxadiazole is a five-membered heterocyclic organic compound containing two nitrogen atoms and one oxygen atom in its ring. Oxadiazole hybrids have shown the ability to improve glucose tolerance, enhance insulin sensitivity, and reduce fasting blood glucose levels. The mechanisms underlying the antidiabetic effects of oxadiazole involve the modulation of molecular _targets such as peroxisome proliferator-activated receptor gamma (PPARγ), α-glucosidase, α-amylase and GSK-3β which regulate glucose metabolism and insulin secretion. The present review article describes the chemical structure and properties of oxadiazoles and highlights the antidiabetic activity through action on different _targets. The SAR for the oxadiazole hybrids has been discussed in this article, which will pave the way for the design and development of new 1,3,4-oxadiazole derivatives as promising antidiabetic agents in the future. We expect that this article will provide comprehensive knowledge and current innovation on oxadiazole derivatives with antidiabetic potential and will fulfil the needs of the scientific community in designing and developing efficacious antidiabetic agents.

Keywords: Antidiabetic drug _targets; Diabetes; GSK-3β.; SAR; Type 2 diabetes; oxadiazole.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ma C.X.; Ma X.N.; Guan C.H.; Li Y.D.; Mauricio D.; Fu S.B.; Cardiovascular disease in type 2 diabetes mellitus: Progress toward personalized management. Cardiovasc Diabetol 2022,21(1),74 - DOI - PubMed
    1. Pradhan T.; Gupta O.; Kumar V.; Sristi; Chawla, G. A comprehensive review on the antidiabetic attributes of thiazolidine‐4‐ones: Synthetic strategies and structure–activity relationships. Arch Pharm (Weinheim) 2023,356(2),2200452 - DOI - PubMed
    1. Tattersall R.B.; Matthews D.R.; The history of diabetes mellitusTextbook of Diabetes 2010,1-23
    1. Rowley W.R.; Bezold C.; Arikan Y.; Byrne E.; Krohe S.; Diabetes 2030: Insights from yesterday, today, and future trends. Popul Health Manag 2017,20(1),6-12 - DOI - PubMed
    1. Tomic D.; Shaw J.E.; Magliano D.J.; The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol 2022,18(9),525-539 - DOI - PubMed
  NODES
COMMUNITY 2
innovation 1
twitter 2